Home > Protocol Summaries: Compounds > fondaparinux sodium Protocol Summaries: fondaparinux sodium GSKStudy ID Phase Title Status 103413 phase 3 An International Randomized Study Evaluating the Efficacy and Safety of Fondaparinux Versus Control Therapy in a Broad Range of Patients With ST Segment Elevation Acute Myocardial Infarction. Completed 103414 phase 3 A multicenter, randomized, double-blind, parallel group trial to demonstrate the efficacy of fondaparinux sodium in association with Intermittent Pneumatic Compression (IPC) versus IPC used alone for the prevention of venous thromboembolic events in subjects at increased risk undergoing major abdomi Completed 103420 phase 3 An international, randomized, double-blind study evaluating the efficacy and safety of fondaparinux versus enoxaparin in the acute treatment of unstable angina/non ST-segment elevation MI acute coronary syndromes Completed 106206 phase 3 Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in the Treatment of Acute Pulmonary Thromboembolism (PE) Completed 107915 phase 4 ArchiMed Hospital : Prevention of venous thromboembolic events with ARIXTRA® 2,5 mg for medical ill patients. Completed 108745 phase 4 Systematische Dokumentation von Patienten mit akutem HIT-Verdacht Completed 108888 phase 4 FondaparinUx Trial with Unfractionated Heparin (UFH) during Revascularization in Acute Coronary Syndromes (ACS) (FUTURA). A prospective study evaluating the safety of two regimens of adjunctive intravenous UFH during PCI in high risk patients with Unstable Angina/Non ST segment elevation myocardial infarction (UA/NSTEMI) initially treated with subcutaneous fondaparinux and referred for early coronary angiography (OASIS 8) Completed 109350 phase 3 A Multicentre, Randomized, Open-label Study to Evaluate the Efficacy andSafety of Fondaparinux versus Low Molecular Weight Heparin(Nadroparin) in Patients Requiring Rigid or Semi-rigid Immobilization for at least 21 Days and up to 45 Days because of Isolated Non-surgical Below-Knee Injury Completed 111418 phase 2 An International, Multicentre, Randomised, Open, Controlled, Two-parallel Group, Phase II Pilot Study to Evaluate the Efficacy and Safety of ARIXTRA™ for Anticoagulation of Patients with Atrial Fibrillation undergoing Electric Cardioversion Following Transesophageal Echocardiography Completed 111436 phase 3 Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in the Treatment of Acute Deep Vein Thrombosis (DVT) Completed 112721 phase 4 Special Drug Use Investigation for ARIXTRA (fondaparinux) Abdominal (Urology,Obstetrics,Gynecology) Active not recruiting 112797 phase 4 Special Drug Use Investigation for ARIXTRA (fondaparinux) Abdominal General Surgery Active not recruiting 112937 phase 4 Retrospektive Studie zu Patientinnen, die pränatal, perinatal oder postnatal prophylaktisch oder therapeutisch mit Fondaparinux behandelt wurden Completed 113164 phase 4 Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery Completed 113652 n\a Evaluate (post approval) the adherence to the prescribing information for ARIXTRA® (fondaparinux) in ACS patients- commitment of the fondaparinux EU-RMP Completed 113822 Risk score for venous thromboembolism Completed 113962 n\a Risk of hemorrhage in patients prescribed Arixtra compared to LMWH Completed 115280 ARIXTRA® Physician Adherence to the Prescribing Information in isolated superficial vein thrombosis (SVT) Patients. Active not recruiting 115489 Special Drug Use Investigation for Arixtra® (fondaparinux) Venous Thromboembolism Treatment Not yet recruiting 115490 Special Drug Use Investigation (retrospective) for Arixtra® (fondaparinux) Venous Thromboembolism Treatment (over 100kg) Not yet recruiting 116320 n\a Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5) (1) Completed 116589 phase 4 Anti-Xa activity of fondaparinux for venous thromboembolism (VTE) treatment Recruiting AR3106116 Phase 3 Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) after Abdominal Surgery Completed AR3106333 Phase 3 Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism after Elective Total Hip Replacement Surgery Completed AR3106335 Phase 3 Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism after Hip Fracture Surgery Completed ART108053 phase 3 See Detailed Description Completed ITI105316 Phase 3 Randomized, single blind, parallel study to compare the safety and efficacy of ARIXTRA to Enoxaparine in patients undergoing elective major hip or knee replacement or a revision of components. Completed
